Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus plus low-dose prednisolone versus high-dose prednisolone in minimal change nephrotic syndrome
2015-001039-18Phase 3
- Sponsor
- Astellas Pharma
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus, prednisolone in nephrosis, sponsored by Astellas Pharma.
02
Drugs
tacrolimusprednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2015-001039-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001039-18.